rent-now

Rent More, Save More! Use code: ECRENTAL

5% off 1 book, 7% off 2 books, 10% off 3+ books

9781890504892

A Guide to Oncology Symptom Management

by
  • ISBN13:

    9781890504892

  • ISBN10:

    1890504890

  • Edition: 1st
  • Format: Paperback
  • Copyright: 2009-10-30
  • Publisher: Oncology Nursing Society
  • Purchase Benefits
  • Free Shipping Icon Free Shipping On Orders Over $35!
    Your order must be $35 or more to qualify for free economy shipping. Bulk sales, PO's, Marketplace items, eBooks and apparel do not qualify for this offer.
  • eCampus.com Logo Get Rewarded for Ordering Your Textbooks! Enroll Now
List Price: $105.00

Summary

Oncology nurses provide care to people who experience multiple and varied symptoms and conditions that are related to the cancer itself, its treatment, or other comorbid conditions. Providing this care requires evidence-based information on appropriate interventions. A Guide to Oncology Symptom Managementaddresses major symptoms and conditions experienced by patients with cancer, using the most current and relevant evidence as a framework.

Author Biography

Carlton G. Brown, PhD, RN, AOCN has been an oncology nurse for more than 20 years, working as a staff nurse, nurse manager, clinical nurse specialist, educator, and nurse researcher. He received his Bachelor of Science in Nursing from the University of Louisville, his Master of Science in Nursing from the University of Pennsylvania, and his PhD from the University of Utah. Dr. Brown is a past president of the Oncology Nursing Certification Corporation and will become the president of the Oncology Nursing Society in 2010. He is currently an assistant professor at the University of Delaware, College of Health Sciences, School of Nursing, in Newark, DE. Dr. Brown has a particular interest in symptoms related to cancer treatment, and his doctoral dissertation focused on oral mucositis and other associated symptoms.

Table of Contents

Forewordp. xiii
Acknowledgmentsp. xiv
Symptoms in Older Adultsp. 1
Case Studyp. 1
Overviewp. 1
Overview of Normal Agingp. 2
Common Health Issues in the Aging Populationp. 4
Cancer-Related Symptom Issuesp. 6
Pharmacologic Managementp. 9
Nonpharmacologic Managementp. 11
Symptom Management Outcomesp. 12
Need for Future Researchp. 12
Conclusion of Case Studyp. 12
Conclusionp. 13
Referencesp. 14
Alopeciap. 17
Case Studyp. 17
Overviewp. 17
Pathophysiologyp. 18
Hair Loss During Cancer Treatmentp. 19
Preventing Hair Lossp. 20
Human Responses to Hair Lossp. 22
Clinical Practice Recommendationsp. 23
Conclusion of Case Studyp. 24
Conclusionp. 25
Referencesp. 25
Anemiap. 29
Case Studyp. 29
Overviewp. 29
Pathophysiologyp. 30
Assessmentp. 35
Evidence-Based Interventionsp. 37
Standing Ordersp. 42
Expected Outcomesp. 42
Patient Teaching Pointsp. 44
Need for Future Researchp. 44
Conclusion of Case Studyp. 45
Conclusionp. 45
Referencesp. 45
Anxiety and People With Cancerp. 49
Case Studyp. 49
Overviewp. 49
Incidencep. 50
Pathophysiologyp. 52
Assessmentp. 53
Measurementp. 54
Evidence-Based Interventionsp. 54
Psychosocial Interventionsp. 55
Pharmacologic Interventionsp. 56
Complementary Therapiesp. 60
Expected Outcomesp. 60
Patient Teaching Pointsp. 60
Need for Future Researchp. 61
Conclusion of Case Studyp. 62
Conclusionp. 62
Referencesp. 62
Cancer Cachexiap. 65
Case Studyp. 65
Overviewp. 65
Pathophysiologyp. 66
Assessmentp. 69
Treatmentp. 71
Evidence-Based Interventionsp. 72
Patient Teaching Pointsp. 82
Need for Future Researchp. 83
Conclusion of Case Studyp. 83
Conclusionp. 84
Referencesp. 84
Chemotherapy-Induced Nausea and Vomitingp. 91
Case Studyp. 91
Overviewp. 91
Prevalence of Chemotherapy-Induced Nausea and Vomitingp. 93
Pathophysiologyp. 94
Impact of Chemotherapy-Induced Nausea and Vomitingp. 96
Risk Factorsp. 98
Continuation of Case Studyp. 101
Assessmentp. 101
Evidence-Based Interventionsp. 103
Nonpharmacologic Managementp. 112
Need for Future Researchp. 114
Conclusion of Case Studyp. 115
Conclusionp. 116
Referencesp. 116
Cognitive Impairmentp. 123
Case Studyp. 123
Overviewp. 123
Descriptions and Consequences of Cognitive Impairmentp. 124
Pathophysiologyp. 125
Assessmentp. 129
Interventionsp. 131
Patient Teaching Pointsp. 132
Need for Future Researchp. 134
Conclusion of Case Studyp. 134
Conclusionp. 135
Referencesp. 135
Constipationp. 139
Case Studyp. 139
Overviewp. 139
Pathophysiologyp. 141
Assessmentp. 143
Management and Evidence-Based Interventionsp. 145
Preventionp. 147
Laxativesp. 148
Enemasp. 149
Nonpharmacologic Interventionsp. 150
Obstipationp. 150
Patient Teaching Pointsp. 150
Need for Future Researchp. 151
Conclusion of Case Studyp. 151
Conclusionp. 152
Referencesp. 152
Depressionp. 153
Case Studyp. 153
Overviewp. 153
Pathophysiologyp. 155
Assessmentp. 156
Evidence-Based Interventionsp. 158
Patient Teaching Pointsp. 166
Need for Future Researchp. 167
Conclusion of Case Studyp. 168
Conclusionp. 169
Referencesp. 169
Diarrheap. 173
Case Studyp. 173
Overviewp. 173
Definitionp. 173
Incidencep. 174
Risk Factorsp. 176
Pathophysiologyp. 177
Causesp. 177
Osmotic Diarrheap. 178
Malabsorptive Diarrheap. 178
Secretory Diarrheap. 178
Infectious Diarrheap. 180
Dysmotility-Associated Diarrheap. 180
Chemotherapy-Induced Diarrheap. 181
Radiation-Induced Diarrheap. 182
Assessmentp. 182
Evidence-Based Interventionsp. 186
Nonpharmacologic Interventionsp. 187
Pharmacologic Interventionsp. 190
Expected Outcomesp. 193
Patient and Family Teaching Pointsp. 194
Need for Future Researchp. 194
Conclusion of Case Studyp. 195
Conclusionp. 195
Referencesp. 195
Dyspneap. 199
Case Studyp. 199
Overviewp. 199
Assessmentp. 202
Evidence-Based Interventionsp. 208
Expected Outcomesp. 215
Patient Teaching Pointsp. 215
Need for Future Researchp. 218
Conclusion of Case Studyp. 219
Conclusionp. 220
Referencesp. 220
Electrolyte Imbalances, Tumor Lysis Syndrome, and Syndrome of Inappropriate Antidiuretic Hormonep. 225
Case Studyp. 225
Electrolyte Imbalancesp. 225
Syndrome of Inappropriate Antidiuretic Hormonep. 256
Tumor Lysis Syndromep. 260
Conclusion of Case Studyp. 267
Conclusionp. 267
Referencesp. 267
Cancer-Related Fatiguep. 271
Case Studyp. 271
Overviewp. 271
Pathophysiologyp. 274
Assessmentp. 276
Evidence-Based Interventionsp. 281
Expected Outcomesp. 287
Patient and Family Teaching Pointsp. 287
Need for Future Researchp. 288
Conclusion of Case Studyp. 289
Conclusionp. 290
Referencep. 290
Hot Flashesp. 299
Case Studyp. 299
Overviewp. 299
Risk Factorsp. 300
Pathophysiologyp. 301
Assessmentp. 303
Evidence-Based Interventionsp. 303
Pharmacologic Interventionsp. 305
Nonpharmacologic Interventionsp. 307
Patient Teaching Pointsp. 308
Need for Future Researchp. 308
Conclusion of Case Studyp. 309
Conclusionp. 309
Referencesp. 309
Lymphedemap. 315
Case Studyp. 315
Overviewp. 315
Quality of Lifep. 318
Pathophysiologyp. 319
Assessmentp. 321
Treatmentp. 322
Expected Outcomesp. 328
Patient Teaching Pointsp. 328
Need for Future Researchp. 329
Conclusion of Case Studyp. 329
Conclusionp. 330
Referencesp. 330
Oral Mucositisp. 333
Case Studyp. 333
Overviewp. 333
Risk Factors and Associated Incidencep. 334
Pathophysiologyp. 336
Assessmentp. 338
Interventionsp. 339
Patient Teaching Pointsp. 342
Expected Outcomesp. 342
Need for Future Researchp. 343
Conclusion of Case Studyp. 343
Conclusionp. 343
Referencesp. 344
Neutropenia and Infectionp. 347
Case Studyp. 347
Overviewp. 347
Definitionsp. 347
Risk Factorsp. 349
Pathophysiologyp. 351
Assessmentp. 351
Interventionsp. 353
Patient Teaching Pointsp. 358
Need for Future Researchp. 359
Conclusion of Case Studyp. 359
Conclusionp. 359
Referencesp. 359
Osteoporosis and Bone Healthp. 363
Case Studyp. 363
Overviewp. 363
Epidemiology: Prevalence and Impactp. 364
Risk Factorsp. 365
Pathophysiologyp. 369
Screeningp. 372
Assessmentp. 372
Diagnosisp. 373
Case Study (Part 2)p. 375
Prevention and Treatmentp. 376
Case Study (Part 3)p. 378
Pharmacologic Treatmentp. 378
General Principles of Treatmentp. 380
Patient Teaching Pointsp. 380
Conclusion of Case Studyp. 381
Conclusionp. 382
Referencesp. 382
Cancer Painp. 389
Case Studyp. 389
Overviewp. 389
Pathophysiologyp. 390
Assessmentp. 391
Evidence-Based Interventionsp. 392
Principles of Cancer Pain Managementp. 392
Pharmacologic Cancer Pain Managementp. 394
Nonpharmacologic Cancer Pain Managementp. 399
Expected Outcomesp. 399
Patient Teaching Pointsp. 399
Need for Future Researchp. 400
Conclusion of Case Studyp. 400
Conclusionp. 401
Referencesp. 401
Peripheral Neuropathyp. 405
Case Studyp. 405
Overviewp. 405
Definitionp. 406
Incidencep. 407
Risk Factorsp. 408
Pathophysiologyp. 410
Characteristics of Peripheral Neuropathyp. 411
Assessmentp. 411
Testsp. 412
Gradingp. 414
Evidence-Based Interventionsp. 416
Expected Outcomesp. 416
Patient Teaching Pointsp. 417
Need for Future Researchp. 417
Conclusion of Case Studyp. 418
Conclusionp. 419
Referencesp. 419
Altered Sexuality Patternsp. 423
Case Studyp. 423
Overviewp. 423
Erectile Dysfunctionp. 424
Dyspareuniap. 429
Altered Body Imagep. 433
Changes in Libidop. 436
Infertilityp. 440
Expected Outcomes for Altered Sexuality Patternsp. 447
Patient Teaching Points for Altered Sexuality Patternsp. 448
Need for Future Research for Altered Sexuality Patternsp. 449
Conclusion of Case Studyp. 449
Conclusionp. 450
Referencesp. 450
Skin and Nail Alterationsp. 457
Case Studyp. 457
Overviewp. 457
Nail Bed Changesp. 459
Hyperpigmentationp. 461
Paronychia and Onycholysisp. 462
Palms and Solesp. 462
Incidence of Rash: Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitorsp. 463
Pathophysiologyp. 464
Assessmentp. 465
Interventions for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Rashp. 466
Patient Teaching Pointsp. 468
Need for Future Researchp. 469
Conclusion of Case Studyp. 469
Conclusionp. 469
Referencesp. 470
Sleep-Wake Disturbancesp. 473
Case Studiesp. 473
Overviewp. 474
Sleep Physiologyp. 475
Sleep-Wake Disturbances in Patients With Cancerp. 478
Assessment of Sleep-Wake Disturbancesp. 480
Evidence-Based Interventionsp. 482
Expected Outcomesp. 489
Patient and Family Teaching Pointsp. 489
Need for Future Researchp. 489
Conclusion of Case Studiesp. 490
Conclusionp. 491
Referencesp. 491
Spiritual Care From the Oncology Nursep. 497
Case Studyp. 497
Overviewp. 497
Meaning of Spiritualityp. 497
What Patients Have to Say About the Spiritp. 498
Prerequisites and Self-Care for Engagement in Spiritual Carep. 499
Assessment of Spiritual Needsp. 500
Application of FICA to Case Studyp. 502
Interventionsp. 502
Community-Based Spiritual Carep. 506
Interventions in the Case Studyp. 506
Conclusionp. 506
Referencesp. 507
Indexp. 509
Table of Contents provided by Ingram. All Rights Reserved.

Supplemental Materials

What is included with this book?

The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.

The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.

Rewards Program